Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT2015012020736N1Phase 3Completed
Phase 3 trial of recombinant human chorionic gonadotrophin in female infertility, sponsored by Tehran University of Medical Sciences. Started Dec 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT2015012020736N1.